Blueprint Medicines
BPMC
#2177
Rank
C$10.38 B
Marketcap
$163.44
Share price
-1.33%
Change (1 day)
52.88%
Change (1 year)

EPS for Blueprint Medicines (BPMC)

EPS in 2023 (TTM): -$12.39

According to Blueprint Medicines 's latest financial reports the company's current EPS (TTM) is -$13.35. In 2022 the company made an earnings per share (EPS) of -$13.58 an increase over its 2021 EPS that were of -$15.95.

EPS history for Blueprint Medicines from 2014 to 2023

Annual EPS

Year EPS Change
2023 (TTM)-$12.39-8.73%
2022-$13.58-14.85%
2021-$15.95-297.13%
2020$8.09-176.3%
2019-$10.6035.19%
2018-$7.8438.82%
2017-$5.6547.35%
2016-$3.839.25%
2015-$3.51-31.35%
2014-$5.11

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
-$0.10-99.24%๐Ÿ‡บ๐Ÿ‡ธ USA
-$0.39-97.06%๐Ÿ‡บ๐Ÿ‡ธ USA
-$1.84-86.18%๐Ÿ‡บ๐Ÿ‡ธ USA